Skip to main content
    C

    CNS Pharmaceuticals Inc (CNSP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.48
    +0.59 (+20.42%)

    Market Cap: $4.22M

    Last updated: Nov 17, 2026 at 10:56 AM ET

    CNS Pharmaceuticals Inc (CNSP) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to CNS Pharmaceuticals are PharmaCyte Biotech (PMCB), Processa Pharmaceuticals (PCSA) and Traws Pharma (TRAW). By market cap, CNS Pharmaceuticals ranks 5th of the 13 companies on this page; Lantern Pharma (LTRN) is the largest at $6.47M.

    Peer Comparison

    CNSP's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    CNS Pharmaceuticals (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Processa Pharmaceuticals Inc (PCSA)$5.20MN/AN/A0.0%N/A0.0%0.00%
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    NuCana PLC (NCNA)$3.88MN/AN/A0.0%N/A0.0%0.00%
    Lantern Pharma Inc (LTRN)$6.47MN/AN/A0.0%N/A0.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Clearmind Medicine Inc. Common Shares (CMND)$2.30MN/AN/A0.0%-56.8%0.0%0.00%
    Can Fite Biopharma Ltd ADR (CANF)$4.30MN/A14.3x0.0%-156.8%0.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Peer median$3.87MN/A7.9x0.0%-202.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to CNS Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Processa Pharmaceuticals Inc (PCSA)
    Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients...
    PCSA competitors
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...
    NuCana PLC (NCNA)
    NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer.
    NCNA competitors
    Lantern Pharma Inc (LTRN)
    Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics...
    LTRN competitors
    Skye Bioscience, Inc. Common Stock (SKYE)
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    Clearmind Medicine Inc. Common Shares (CMND)
    Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems.
    CMND competitors
    Can Fite Biopharma Ltd ADR (CANF)
    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer...
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors

    Frequently Asked Questions About CNSP

    Who are CNS Pharmaceuticals' main competitors?

    The companies most similar to CNS Pharmaceuticals include PharmaCyte Biotech (PMCB), Processa Pharmaceuticals (PCSA), Traws Pharma (TRAW), Curis (CRIS) and Neurosense Therapeutics (NRSN), listed from the closest match.

    Who is CNS Pharmaceuticals' biggest competitor?

    Lantern Pharma (LTRN) is the largest of the similar companies at $6.47M; PharmaCyte Biotech (PMCB) is the closest match by business profile, size, sector and industry.

    How does CNSP stock compare with its competitors?

    CNSP's net margin is 0.0% against a peer median of 0.0%.

    Which of CNS Pharmaceuticals' competitors pays a higher dividend?

    CNS Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is CNS Pharmaceuticals bigger than its competitors?

    No. CNS Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Lantern Pharma (LTRN) at $6.47M.